Antiretroviral Agents in HIV-1 (2014)

Timepoint/Frequency of Testing Every 3-6 Months Every 6 Months Every 12 Months Treatment Failure Clinically Indicated During first 2 years of ART or if viremia develops while patient on ART or CD4 count <300 cells/mm 3 Aer 2 years on ART with consistently suppressed viral load: • CD4 Count 300-500 cells/mm 3 : > Every 12 months • CD4 Count >500 cells/mm 3 : > CD4 monitoring is optional If considering a CCR5 antagonist or for failure of CCR5 antagonist- based regimen 9

• Cover